PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 8, 2013BMJ393 citationsOpen Access

Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study

FLFrancesco LapiLALaurent AzoulayHYHui Yin

Structured PICO

Does concurrent use of diuretics, ACE inhibitors or ARBs, and NSAIDs increase the risk of acute kidney injury?

P
Population
Patients receiving antihypertensive drugs (diuretics, angiotensin converting enzyme inhibitors, or angiotensin receptor blockers)
I
Intervention
Triple therapy combination consisting of diuretics, angiotensin converting enzyme inhibitors or angiotensin receptor blockers, and non-steroidal anti-inflammatory drugs (NSAIDs)
O
Outcome
Acute kidney injurysafety

Vigilance is warranted when antihypertensive drugs (diuretics, ACEi/ARBs) are used concurrently with NSAIDs due to an increased risk of acute kidney injury, particularly at the start of treatment.

Abstract

A triple therapy combination consisting of diuretics with angiotensin converting enzyme inhibitors or angiotensin receptor blockers and NSAIDs was associated with an increased risk of acute kidney injury. The risk was greatest at the start of treatment. Although antihypertensive drugs have cardiovascular benefits, vigilance may be warranted when they are used concurrently with NSAIDs.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lapi et al. (2013) studied this question.

synapsesocial.com/papers/69d975ea5e5bcb4e3b836913https://doi.org/10.1136/bmj.e8525
Ask AI
Helpful
Bookmark
Share
View Full Paper